Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | 0.00% | -4.73% | +82.95% |
05-15 | Atossa Therapeutics Doses Last Patient in Phase 2 Karisma-Endoxifen Trial | MT |
05-15 | Atossa Therapeutics, Inc. Announces Last Patient, Last Dose in Its Phase 2 Karisma-Endoxifen Clinical Trial | CI |